Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

Now, the Federal Trade Commission (FTC) is suing the largest PBMs for allegedly increasing the cost of insulin for patients with diabetes. These middlemen manage the drug benefits for virtually ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

By taking steps to hold middlemen ... Affordable Insulin Now Act moves towards the US Senate. Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin ... three PBMs are the ...

In a study presented at the Summit on Stem Cell Derived Islets in Boston, researchers report on encouraging results using an ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

INSULIN LITIGATION DEEP-DIVE — As Congress ... in a New Jersey district court against the three major pharmacy middlemen — CVS Caremark, Express Scripts and OptumRx — and three insulin ...

“Your drug has a generic” that may cost less. In the case of insulin, if the generic is covered, it won’t cost less but chances are the plan will save money. And that can be a factor in what ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...